pharma news, views and analysis - pharmaphorum.com

Trending

in News
Supply chain middlemen ‘pocket half of US branded medicine spending’
January 13, 2022 Share
X
Supply chain middlemen ‘pocket half of US branded medicine spending’
https://pharmaphorum.com/news/supply-chain-middlemen-pocket-half-of-us-branded-medicine-spending/
in News
Medicare limits Aduhelm coverage to clinical trial participants
January 12, 2022 Share
X
Medicare limits Aduhelm coverage to clinical trial participants
https://pharmaphorum.com/news/medicare-limits-aduhelm-coverage-to-clinical-trial-participants/

Latest News

Regeneron hands ex-US rights to HoFH drug Evkeeza to Ultragenyx

Regeneron hands ex-US rights to HoFH drug Evkeeza to Ultragenyx

Regeneron has enlisted the aid of Ultragenyx to add momentum to the rollout of its recently-approved Evkeeza outside

X

Regeneron hands ex-US rights to HoFH drug Evkeeza to Ultragenyx

https://pharmaphorum.com/news/regeneron-hands-ex-us-rights-to-hofh-drug-evkeeza-to-ultragenyx/

Another mRNA company gets snapped up as Merck buys Exelead

Another mRNA company gets snapped up as Merck buys Exelead

The latest pharma company to make a move for an mRNA specialist is Germany’s Merck KGaA, which has

X

Another mRNA company gets snapped up as Merck buys Exelead

https://pharmaphorum.com/news/another-mrna-company-gets-snapped-up-as-merck-buys-exelead/

Novartis blocks generic to MS blockbuster Gilenya in US patent dispute

Novartis blocks generic to MS blockbuster Gilenya in US patent dispute

Novartis has blocked an attempt by Chinese drugmaker HEC Pharma to launch a generic version of its big-selling

X

Novartis blocks generic to MS blockbuster Gilenya in US patent dispute

https://pharmaphorum.com/news/novartis-defends-ms-blockbuster-gilenya-in-patent-dispute/

Views & Analysis

Content metrics help generate compelling communication

Content metrics help generate compelling communication

Companies seek efficiency and speed to market during the content creation process, review and approval cycles, and thus

X

Content metrics help generate compelling communication

https://pharmaphorum.com/sales-marketing/content-metrics-help-generate-compelling-communication/

Don’t be afraid to change

Don’t be afraid to change

The digital revolution generated by the pandemic fractured lines of connection and severed the life-blood of being able

X

Don’t be afraid to change

https://pharmaphorum.com/sales-marketing/60-seconds-dont-be-afraid-to-change/

Cutting through the Noise

Cutting through the Noise

The pandemic has given us a surge of opportunities to take fresh looks at how we live, work

X

Cutting through the Noise

https://pharmaphorum.com/sales-marketing/cutting-through-the-noise/

Debates & Insights

How to optimise pharma’s digital HCP engagement

How to optimise pharma’s digital HCP engagement

Pharmaceutical companies face a ‘digital imperative’ to engage with healthcare professionals through their preferred mix of channels if

X

How to optimise pharma’s digital HCP engagement

https://pharmaphorum.com/debates-insight-sales-marketing/how-to-optimise-pharmas-digital-hcp-engagement/

Ensuring delivery of healthcare professional education

Ensuring delivery of healthcare professional education

Pharma companies always need to know they can get the right information to the right people at the

X

Ensuring delivery of healthcare professional education

https://pharmaphorum.com/debates-insight-sales-marketing/ensuring-delivery-of-healthcare-professional-education/

Good data supports pharma sales reps to drive lead generation

Good data supports pharma sales reps to drive lead generation

Allow pharma sales reps to focus on the job in hand by making sure they have access to

X

Good data supports pharma sales reps to drive lead generation

https://pharmaphorum.com/sales-marketing/good-data-supports-pharma-sales-reps-to-drive-lead-generation/

Partner Content

PRISYM ID Achieves Zebra Technologies Validation

PRISYM ID Achieves Zebra Technologies Validation

PRISYM ID Achieves Zebra Technologies Validation

X

PRISYM ID Achieves Zebra Technologies Validation

https://pharmaphorum.com/partner-content/prisym-id-achieves-zebra-technologies-validation/

Identifying Rising Stars

Identifying Rising Stars

The term ‘Rising Stars’ is often used throughout the pharma industry. In general, rising stars within a given

X

Identifying Rising Stars

https://pharmaphorum.com/partner-content/identifying-rising-stars/

How Label Management Solutions Can Help CDMOS Grow Their In-House Capabilities

How Label Management Solutions Can Help CDMOS Grow Their In-House Capabilities

HOW LABEL MANAGEMENT SOLUTIONS CAN HELP CDMOS GROW

X

How Label Management Solutions Can Help CDMOS Grow Their In-House Capabilities

https://pharmaphorum.com/partner-content/how-label-management-solutions-can-help-cdmos-grow-their-in-house-capabilities/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com